Quality Assurance and Legal Issues in Healthcare

Chapter 2: Quality Assurance and Legal Issues in Healthcare

Objectives

  • Demonstrate knowledge of terminology for national organizations, agencies, and regulations supporting quality assurance in healthcare.

  • Define quality and performance improvement measurements related to phlebotomy.

  • Describe components of a quality assurance (QA) program for phlebotomy.

  • Identify areas in phlebotomy subject to quality control (QC).

  • Outline legal aspects associated with phlebotomy procedures and situations with legal ramifications.

Quality Assurance in Healthcare

  • Quality: Degree of excellence of care.

  • Quality Assurance (QA): Activities ensuring excellence in patient care.

  • Continuous Quality Improvement (CQI): Ongoing system for monitoring and improving healthcare quality.

National Standard and Regulatory Agencies

The Joint Commission (TJC)

  • Independent organization setting healthcare standards.

  • Focus on improving patient safety and quality of care.

  • Implements Survey Analysis for Evaluating Risk (SAFERTM) since 2017 to visualize survey results and prioritize corrective actions.

  • Sentinel Event (SE) Policy: Identifies safety issues and mandates action plans following sentinel events.

  • National Patient Safety Goals (NPSGs) for 2018 include:

    • Identifying patients correctly.

    • Improving staff communication.

    • Preventing infections.

Clinical Laboratory Improvement Amendments (CLIA)

  • Federal regulations ensuring quality standards across laboratories.

  • Address QA, QC, proficiency testing, laboratory records, and personnel qualifications.

  • Specimen collection is part of CLIA oversight.

College of American Pathologists (CAP)

  • Focuses solely on pathology/lab services with ongoing inspections and proficiency testing.

  • Ensures documentation confirms employee qualifications.

Clinical and Laboratory Standards Institute (CLSI)

  • Develops voluntary guidelines and standards for laboratory practices.

National Accrediting Agency for Clinical Laboratory Sciences (NAACLS)

  • Provides accreditation for clinical laboratory sciences educational programs.

International Organization for Standardization (ISO)

  • Develops voluntary international standards for various industries.

Quality Assurance in Phlebotomy

QA Processes

  • Failure Modes & Effects Analysis (FMEA): Identifying potential failures.

  • Six Sigma: Methodology for process improvement.

  • Lean Methodology: Efficiency improvements in workflows.

  • Root-Cause Analysis (RCA): Identifying underlying causes of issues.

Quality Indicators

  • Must be measurable, well-defined, objective, specific, and related to important aspects of care.

Thresholds & Data

  • Threshold value: Acceptable practice level; exceeding triggers evaluation and corrective actions.

Process & Outcomes

  • Continuous review of both processes and outcomes is necessary for improvement.

  • Quality Control (QC): Ensures procedures are performed correctly through operational checks.

Areas of Phlebotomy Subject to QA

  • Patient preparation procedures and specimen collection techniques.

  • Includes patient identification, labeling, techniques, and collection priorities.

Documentation

Patient’s Record

  • Chronological documentation required by law, aims to improve medical practice and communication, and serves legal purposes.

Test Catalogs and Reference Manuals

  • Outline preparation requirements and specimen handling protocols.

Procedure Manual

  • Includes policies and procedures for laboratory tests, updated annually.

Safety Manual

  • Contains safety procedures for various hazards and emergency protocols.

QA Forms

  • Include equipment checks and internal reports detailing incidents and corrections.

Risk Management

  • Definition: Identifying and minimizing risks to patients and employees.

  • Steps involve identification, treatment, education, and evaluation of risks.

Individualized Quality Control Plan (IQCP)

  • Tailors quality control approaches specific to laboratory needs and populations.

Sexual Harassment

  • Defined as persistent or offensive conduct affecting a person's job; governed by Title VII of the Civil Rights Act.

Legal Issues in Healthcare

Tort

  • Wrongful acts against a person, property, or reputation, intentional or not.

  • Types include assault, battery, fraud, invasion of privacy, malpractice, and negligence.

Malpractice Insurance

  • Provides coverage for malpractice liabilities; typically doesn't target individual employees directly but may involve them as co-defendants.

Avoiding Lawsuits

  • Obtain informed consent, identity patients and specimens meticulously, monitor patients, and maintain confidentiality.

Types of Consent

  • Informed Consent: Requires competent permission with adequate information.

  • Expressed Consent: Specific agreement detailing procedures, preferably in writing.

  • Implied Consent: Inferred from patient actions, often used in emergencies.

  • Consent for Minors: Requires parental or guardian consent.

  • Refusal of Consent: Patients retain the right to refuse treatment.

Litigation Process

  • Phases include recognizing incidents, consulting attorneys, possibly negotiating settlements, and if needed, trial procedures.

NAACLS Entry-Level Competencies Met in This Chapter

  • Discuss legal and ethical importance in patient/sample identification, QA in blood collection, applicable policies, and medicolegal terms.

robot